Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer

NCT00002529 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

452

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: epirubicin hydrochloride
DRUG: tamoxifen citrate
DRUG: toremifene

Sponsor

ETOP IBCSG Partners Foundation